Primary Information |
---|
BoMiProt ID | Bomi353 |
---|
Protein Name | Secretoglobin family 1D member |
---|
Organism | Bos taurus |
---|
Uniprot ID | A0JNP2 |
---|
Milk Fraction | Whey, MFGM |
---|
Ref Sequence ID | NP_001071275.1 |
---|
Aminoacid Length | 102 |
---|
Molecular Weight | 11294 |
---|
FASTA Sequence |
Download |
---|
Gene Name | SCGB1D |
---|
Gene ID | 338419 |
---|
Protein Existence Status | Reviewed: Protein inferred from homology |
---|
Secondary Information |
---|
Presence in other biological fluids/tissue/cells | breast carcinomas, estrogen receptor positive tumors; abundantly expressed in normal
and malignant tissue from the breast, cervix, uterus, ovary,
kidney and prostate; Lower or rare lipophilin B expression
was found in normal colon, pancreas, heart, in gastric and
rectal tumors, and as previously reported in normal testis
and placenta and lung tumors; lipophilin B expression was also detected in the
normal anterior pituitary and pituitary adenomas, in
normal adrenal gland, cartilage, retina, skin,
and salivary gland |
---|
Protein Function | Secretoglobins are small, secreted proteins increasingly recognized for their prognostic capacity in a variety of human cancers, though the precise pathophysiologic functions for most members remain to be elucidated |
---|
Biochemical Properties | Also known as lipophilin B; small and secretory; dimeric proteins; in breast cancer mammaglobin A and lipophilin B proteins
form a covalent complex, and that the two proteins are
bonded in a head-to-tail orientation; lipophilin
binds PS, PA, or PG preferentially over PC |
---|
Significance in milk | More in colustrum; role in lipid droplet transport and nutrient delivery |
---|
Site(s) of PTM(s)
N-glycosylation,
O-glycosylation,
Phosphorylation
| |
---|
Predicted Disorder Regions | NA |
---|
DisProt Annotation | |
---|
TM Helix Prediction | 1TMH; (7-29) |
---|
Bibliography | 1. Boggs, J. M. et al. (1977) ‘Lipid phase separation induced by a hydrophobic protein in phosphatidylserine-phosphatidylcholine vesicles’, Biochemistry, 16(11), pp. 2325–2329. doi: 10.1021/bi00630a003. 2. Ni, J. et al. (2000) ‘All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster.’, Annals of the New York Academy of Sciences, 923(1), pp. 25–42. doi: 10.1111/j.1749-6632.2000.tb05517.x. 3. Sjödin, A. et al. (2003) ‘Dysregulated secretoglobin expression in human lung cancers.’, Lung cancer (Amsterdam, Netherlands), 41(1), pp. 49–56. doi: 10.1016/s0169-5002(03)00126-0. 4. O’Brien, N. et al. (2002) ‘Mammaglobin a: a promising marker for breast cancer.’, Clinical chemistry, 48(8), pp. 1362–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12142396 (Accessed: 3 October 2019). 5. Carter, D. et al. (2003) ‘Serum antibodies to lipophilin B detected in late stage breast cancer patients.’, Clinical cancer research : an official journal of the American Association for Cancer Research, 9(2), pp. 749–54. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12576445 (Accessed: 3 October 2019). 6. Colpitts, T. L. et al. (2001) ‘Mammaglobin Is Found in Breast Tissue as a Complex with BU101’, Biochemistry, 40(37), pp. 11048–11059. doi: 10.1021/bi010284f. 7. Zafrakas, M. et al. (2006) ‘Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies’, BMC Cancer, 6(1), p. 88. doi: 10.1186/1471-2407-6-88. |